R&D 100 Award Earned by Fluxion Biosciences for IsoFlux Circulating Tumor Cell System

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluxion Biosciences, a leading provider of cell analysis platforms for research and diagnostics, today announced that it has won a 2013 R&D 100 Award for its IsoFlux™ System. The R&D 100 Award places the state-of-the-art IsoFlux System in the prestigious company of previous winners such as liquid crystal displays and the anticancer drug Taxol.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC